← Back to Search

Bone Graft

Bone Grafts for Jawbone Width Loss

Phase 4
Recruiting
Led By Eswar Kandaswamy, MS
Research Sponsored by Louisiana State University Health Sciences Center in New Orleans
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-9 months
Awards & highlights

Summary

"This trial aims to study the results of a procedure that enhances the width of the jawbone using a combination of bone material and a collagen membrane that can be absorbed by the body."

Who is the study for?
This trial is for adults over 18 needing bone augmentation before dental implants, who can follow up for 6-9 months, are in good health (ASA I or II), non-smokers, and able to undergo surgery. It's not for those with jaw radiation history, uncontrolled diabetes, HIV/hepatitis, pregnancy plans within 6 months, bisphosphonate use, untreated chronic periodontitis, failed prior implant at the site, immune issues or active infection/pathology at the treatment site.
What is being tested?
The study tests horizontal ridge augmentation using a mix of demineralized human bone (allograft) layered with animal-derived bone (xenograft) under a collagen membrane. The goal is to see how well this combination works for patients needing more bone width before getting dental implants.
What are the potential side effects?
While specific side effects aren't listed here as it's a surgical procedure rather than drug administration; potential risks may include pain at the surgery site, swelling, bruising and less commonly infection or graft failure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-9 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Amount of graft shrinkage
Amount of horizontal bone gain
Percentage of Vital bone
Secondary study objectives
Incidence of surgical complications

Trial Design

1Treatment groups
Experimental Treatment
Group I: Xenograft and allograftExperimental Treatment1 Intervention
The group will consist of patients receiving horizontal ridge augmentation using a combination of Demineralized Freeze Dried Bone Allograft (DFDBA) layered with xenograft particulate bone using a resorbable collagen membrane. The DFDBA will be used internally in contact with the native bone and xenograft will be layered buccal to it.

Find a Location

Who is running the clinical trial?

Geistlich PharmaUNKNOWN
Louisiana State University Health Sciences Center in New OrleansLead Sponsor
119 Previous Clinical Trials
44,813 Total Patients Enrolled
Eswar Kandaswamy, MSPrincipal InvestigatorLSUHSC School of Dentistry
~9 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top